Neurotoxic agents and devices to treat atrial fibrillation

Details Neurotoxic agents and devices to treat atrial fibrillation Neurotoxic agents and devices to treat atrial fibrillation

2006-05-12

2011-11-08

Lucchesi, Nicholas D (Department: 3763)

Surgery

Means for introducing or removing material from body for...

Treating material introduced into or removed from body...

C604S101010, C604S096010, C607S002000

Reexamination Certificate

active

08052668

ABSTRACT:
Devices and methods to treat atrial fibrillation via inhibition of nerves which innervate the pulmonary vein are provided.

REFERENCES:
patent: 5328471 (1994-07-01), Slepian
patent: 5728068 (1998-03-01), Leone et al.
patent: 5766152 (1998-06-01), Morley et al.
patent: 5919163 (1999-07-01), Glickman
patent: 5947952 (1999-09-01), Morley et al.
patent: 6113584 (2000-09-01), Morley et al.
patent: 2003/0065240 (2003-04-01), Sanders et al.
patent: 2003/0069606 (2003-04-01), Girouard et al.
patent: 2005/0171575 (2005-08-01), Dev et al.
Ahmed, J., et al., “Three-dimensional analysis of pulmonary venous ostial and antral anatomy: implications for balloon catheter-based pulmonary vein isolation.”, J Cardiovasc Electrophysiol., 17(3), (Mar. 2006), 251-5.
Goldstein, J. A, et al., “Comparison of the diameter consistency and dilating force of the controlled radial expansion balloon catheter to the conventional balloon dilators.”, Am J Gastroenterol., 95(12), (Dec. 2000), 3423-7.
Haines, D. E, “With pulmonary vein isolation for paroxysmal atrial fibrillation ablation, one size does not fit all.”, J Cardiovasc Electrophysiol., 13(10), (Oct. 2002), 962-3.
Lesh, M. D, et al., “An anatomic approach to prevention of atrial fibrillation: pulmonary vein isolation with through-the-balloon ultrasound ablation (TTB-USA).”, Thorac Cardiovasc Surg., 47 (Suppl 3), (Aug. 1999), 347-51.
Mansour, M., et al., “Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation.”, J Cardiovasc Electrophysiol., 15(4), (Apr. 2004), 387-93.
Ready, Vivek Y., et al., “Balloon catheter ablation to treat paroxysmal atrial fibrillation: What is the Level of pulmonary venous isolation?”, Heart Rhythm, 5(3), (Mar. 2008), 353-360.
Saliba, Wilber W., et al., “Circumferential ultrasound ablation for pulmonary vein isolation: analysis of acute and chronic failures”, J. Cardiovasc. Electrophysiol, Abstract, (Oct. 2002) 1 page.
Seshadri, N., et al., “Pulmonary vein isolation for treatment of atrial fibrillation: recent updates.”, Pacing Clin Electrophysiol., 26(7 Pt 2), (Jul. 2003), 1636-40.

Affiliated with

Also associated with

Rating

Neurotoxic agents and devices to treat atrial fibrillation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neurotoxic agents and devices to treat atrial fibrillation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neurotoxic agents and devices to treat atrial fibrillation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4283951